Looking at the depth today it could be that Scholz is futher adding to their 15% holding (just a guess)All of this buying depth disappeared for about a week and now its reappeared...
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%